We show here that exposure of cardiac cells to simulated ischemia results in apoptosis and is accompanied by phosphorylation and increased expression and transcriptional activity of STAT-1. Similarly, interferon-␥, which is known to induce STAT-1 activation, also induced apoptosis in cardiac cells. STAT-1-transfected cells were more susceptible to ischemia-induced cell death than cells transfected with a control plasmid lacking the STAT-1 coding sequence. Furthermore, an antisense STAT-1 vector reduced both ischemia-and overexpressed STAT-1-induced cell death in cardiac cells. Both STAT-1 overexpression and interferon-␥ treatment or exposure to ischemia activated the promoter of the pro-apoptotic caspase-1 gene in cardiomyocytes. Finally, ischemia/reperfusion also induced STAT-1 activation and caspase-1 processing in ventricular myocytes in the intact heart ex vivo. Immunofluorescent staining demonstrated an increase in STAT-1-positive staining in cardiomyocytes in response to ischemia/reperfusion that co-localized with terminal deoxynucleotidyl transferase dVTP nick end-labeling-positive apoptotic cells. These results suggest that STAT-1 plays a critical role in the regulation of ischemia/reperfusion-induced apoptosis in cardiac cells, acting at least in part via a caspase-1 activation-dependent pathway.
Loss of cardiomyocytes by programmed cell death (apoptosis) is an important mechanism in the development of cardiac failure during injury due to ischemia/reperfusion and myocardial infarction (1, 2) . Recent studies have indicated that apoptotic death occurs in cardiac cells exposed to a variety of damaging stimuli both in vitro and in the intact heart in vivo (3) (4) (5) (6) . Thus, cardiac cells exposed to a hypoxic/ischemic insult followed by reperfusion undergo apoptotic cell death in vitro (3, 6) . Similarly, apoptotic cell death is also observed in the intact heart following ischemia in vivo (4, 5) . Despite the convincing evidence that apoptosis occurs, the mechanism and signaling pathway that leads to hypoxic/ischemic stimuli resulting in apoptosis in cardiac cells is as yet unknown. However, as in other cell types, caspases have been implicated in apoptotic cell death in cardiomyocytes (7) . For example, the infarct size following ischemia/reperfusion of the intact heart in vivo can be reduced by priming animals with the nonspecific caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone, directly demonstrating the role of caspases in mediating cell death in cardiac cells (8) .
Cytokines and growth factors are known to modulate growth, differentiation, and death in many cell types. For example, interferons (IFNs) 1 have been shown to trigger cell cycle arrest and death in non-cardiac cells (9, 10) , whereas many interleukins stimulate growth and protect cells from apoptosis (11, 12) . These pro-and anti-apoptotic effects are mediated, at least in part, by signaling through a family of transcription factors called STATs. Six STATs have been cloned, some of which exist in different isomeric forms, and all share a high degree of conservation of their structural domains (13, 14) . These include a DNA-binding domain, a site for homo-or heterodimer formation, and also conserved residues for tyrosine and serine phosphorylation by Janus protein kinases (JAKs) and mitogenactivated protein kinases (MAPKs), respectively (15) . STATs phosphorylated by JAK/MAPK dimerize and translocate to the nucleus, where they transactivate STAT-responsive genes.
Recent studies have implicated STATs in both pro-and antiapoptotic signaling. For example, a STAT-1-deficient cell line is resistant to tumor necrosis factor-␣-induced apoptosis (16) , and STAT-1 has been implicated in transcriptional activation of some caspases (17) . In contrast, a dominant-negative form of STAT-3 has been shown to prevent interleukin-6-dependent cell growth and to induce apoptosis in a myeloid cell line (18) . In addition, the ability of IFN-␣/␤ to rescue T cell clones from apoptosis induced by interleukin-2 withdrawal is dependent on STAT-2 (19) , and the anti-apoptotic effects of interleukin-9 appear to involve homo/heterodimers of STAT-1, -3, and -5 (20) .
JAK/STAT signaling pathways have also been implicated in the transduction of extracellular stimuli in the heart. For example, cardiomyocyte hypertrophy induced by cardiotrophin-1 and leukemia inhibitory factor is mediated by JAK/STAT-3 (21, 22) . Moreover, angiotensin II, another cardiomyocyte hypertrophic factor, also signals through a JAK/STAT pathway, although involving different members of the STAT family and with different time kinetics (23) .
In contrast, there is little information on the role of STATs in mediating pro-and anti-apoptotic signals in the heart. In this study, we have therefore investigated whether STATs are involved in apoptotic cell death induced by simulated ischemia/ reperfusion in primary cardiomyocytes in vitro and in the intact heart ex vivo. The data suggest that STAT-1 and STAT-3 play roles in pro-apoptotic and anti-apoptotic signaling, respec-* This work was supported by the British Heart Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. E-mail: anastasis_ Stephanov@yahoo.com tively. Since STAT-1 and STAT-3 can form heterodimers, the molecular constitution of these heterodimers may determine the balance between death and survival of cells in the ischemic myocardium.
MATERIALS AND METHODS
Plasmid Constructs and DNA Transfection-The STAT-1 expression vector was kindly provided by Koichi Nakajima (Osaka University, Osaka, Japan). The STAT-3 expression vector was kindly provided by Shizuo Akira (Hyogo College of Medicine, Hyogo, Japan). The 5Ј-caspase-1 promoter-luciferase reporter construct was kindly provided by Richard Flavell (Yale University, New Haven, CT). The pST1-GL2 vector, which contains the STAT-1-binding site coupled to the luciferase reporter gene, was constructed by ligating the STAT-1 region of SIEm67 (5Ј-GATCTGATTACGGGAAATG-3) into the pGL2-luciferase vector (Promega).
The antisense STAT-1 vector was constructed by inserting the STAT-1 cDNA in the antisense orientation into the pcDNA3 vector. Transfection of reporter constructs and expression vectors into cardiac cells was performed by the calcium phosphate method.
Neonatal Rat Cardiac Cultures and Isolated Intact Heart Using the Langendorff Perfusion Apparatus ex Vivo-Ventricular myocytes isolated from the hearts of neonatal rats (Harlan Sprague-Dawley) that were less than 2 days old were cultured as described previously (24) with the following modifications. After collagenase digestion, the cells were pre-plated in medium consisting of Dulbecco's modified Eagle's medium (1000 mg/liter glucose, 1 mmol/liter L-glutamine, and 100 units/ml penicillin/streptomycin (all from Life Technologies, Inc.)) supplemented with 15% (v/v) fetal calf serum on 10-cm tissue culture dishes. Pre-plating of the cell suspension for 30 min allows contaminating fibroblasts to attach, and the myocytes remain free within the culture medium. Subsequent to this incubation, the cardiomyocyte cell suspension was transferred onto six-well (3-cm) gelatin-coated plates (Falcon) at a density of 10 5 cells/well. This plating system yields cell cultures that are Ͼ95% myocytes as determined by indirect staining with a monoclonal mouse antibody to desmin. After 24 h, the medium was were replaced with the above medium containing reduced fetal calf serum at 1% (v/v) (hereafter referred to as growth medium) for an additional 24 h before experimentation Within 3 days, a confluent monolayer of spontaneously beating myocytes was formed.
To subject the cells to simulated ischemia, the normal growth medium of the cardiomyocyte cultures was replaced with 1 ml of ischemic buffer (137 mM NaCl, 12 mM KCl, 0.49 mM MgCl 2 , 0.9 mM CaCl 2 ⅐H 2 O, 4 mM HEPES, 20 mM sodium lactate, and 10 mM deoxyglucose (pH 6.2; Sigma)), and the cells were incubated at 37°C in an ischemic chamber for 4 h in an atmosphere of 0% oxygen, 5% CO 2 , and balance gas argon. Cell viability was assessed by trypan blue exclusion and TUNEL, immediately after the stress. For control conditions, untreated cells and those treated with IFN-␥ (10 ng/ml; Sigma) or pretreated with the caspase-1-specific inhibitor Tyr-Val-Ala-Asp (BIOMOL Research Labs Inc.) were cultured with 1 ml of modified Esumi control buffer (137 mM CaCl 2 , 3.8 mM KCl, 0.49 mM MgCl 2 , 0.9 mM CaCl 2 , 4 mM HEPES, and 10 mM glucose (pH 7.4)) for 4 h at 37°C in an atmosphere of 5% CO 2 , 21% O 2 , and balance N 2 (normoxic environment). Subsequent to this period, apoptotic cells were assessed by TUNEL or annexin V (see below). In some experiments, cells exposed to simulated ischemia for 4 h were returned to a normoxic environment for a further 16 h.
For the ex vivo studies, hearts were quickly removed and mounted in a Langendorff perfusion apparatus and then perfused with an oxygenated Krebs-Henseleit buffer as described previously (25) . For the induction of ischemia and reoxygenation, the left coronary artery was surgically occluded for 35 min by suture ligation, followed by 2 h of reperfusion. After this period, the hearts were infused with 0.5 ml of 0.25% Evans blue solution to delineate the ischemic area at risk within the left ventricular wall; and either tissues were frozen directly for Western blot analysis, or sections were placed in 4% formaldehyde and then embedded in molten paraffin and frozen until immunofluorescent analysis.
Western Blotting-Cells were exposed to a 4-h non-lethal ischemic insult as described above and harvested immediately or following 24 h of reoxygenation. Approximately 1 ϫ 10 4 cells were harvested in 100 l of 2ϫ concentrated SDS-polyacrylamide gel electrophoresis sample buffer.
Cardiac ventricular tissue (ϳ0.2 g) was homogenized in 0.2 ml of ice-cold lysis buffer (50 mM HCl, 0.1% (v/v) 2-mercaptoethanol, 0.1% Triton X-100, 10 mM Tris (pH 7.5), 1 mM EDTA, and 10 mM phenylmethylsulfonyl fluoride). After centrifugation, the supernatant was removed, and the cells were transferred into 1.5-ml microcentrifuge tubes. Cells were lysed by three 20-s bursts of sonication in 1 ml of ice-cold lysis buffer cooled on ice between each sonication. Tissue debris was removed by centrifugation (12,000 rpm, 10 min, 4°C), and an equal volume of SDS buffer was added to the supernatant, which was boiled for 3 min. Samples were then electrophoresed on a 8% SDS-polyacrylamide gel, transferred to nitrocellulose filters, and subjected to Western blotting with anti-phosphorylated STAT-1, anti-STAT-1, anti-phosphorylated STAT-3, anti-STAT-3, or anti-caspase-1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA).
Immunofluorescence-Immunofluorescent staining was performed as described previously (26) . Briefly, ventricular sections were dewaxed; deparaffined in xylene; and subsequently rehydrated with 100% ethanol, 70% ethanol, and distilled water. Sections were then pretreated in Tris-buffered saline containing 1 mg/ml trypsin, washed with Tris-buffered saline, and incubated with anti-STAT-1 antibody (1:50) for 1 h and subsequently with rhodamine-conjugated secondary antibody for a further 1 h. Sections were thoroughly washed with Trisbuffered saline, and slides were mounted under glass coverslips using antifade mounting medium and examined by confocal fluorescence microscopy. Slides were also prepared in which sections were stained for STAT-1 and TUNEL labeling for co-localization of STAT-1-and TUNEL-positive cells. TUNEL staining was performed using a commercially available kit (Roche Molecular Biochemicals).
Assessing Apoptosis-For TUNEL staining, cardiomyocytes were plated onto 24-well tissue culture dishes. TUNEL assays were performed after the cells were fixed in 4% paraformaldehyde for 30 min at 25°C and washed three times with phosphate-buffered saline. Terminal deoxynucleotidyltransferase reaction solution containing 2 mM fluorescein-conjugated dUTP and 10 units of terminal deoxynucleotidyltransferase (Roche Molecular Biochemicals) was added to the cells for 2 h in a 37°C humidified incubator. After washing with phosphatebuffered saline, the cells were then imaged by fluorescence microscopy. The percentage of apoptotic nuclei is expressed as a percentage of total nuclei. Annexin V labeling was performed following the exposure of cells to a 2-h ischemic insult as described previously (24) .
For assessing the effects of STAT-1, STAT-3, and antisense STAT-1 on ischemia-induced cell death in cardiomyocytes, cells were transiently transfected with 2 g of pCMV-␤-galactosidase plus 2 g of test expression vector. 24 h following transfection, cells were fixed in 0.5% glutaraldehyde and stained with 5-bromo-4-chloro-3-indolyl ␤-D-galactopyranoside. Percentage of cell death was determined by calculating the fraction of blue cells rounded and blebbed as a fraction of total blue cells. All assays were evaluated in triplicate, and the means Ϯ S.E. were calculated.
Band Shift Assays-Cadiac myocytes were treated with 10 ng/ml IFN-␥ for 15 min or exposed to ischemia for 4 h, and cells were harvested in cold phosphate-buffered saline. Nuclear extracts were prepared and used in band shift assays as described previously (27) with a STAT-1 SIEm67 DNA probe that serves as a binding site for STAT-1. For supershift assays, nuclear extracts were incubated with anti-STAT-1 antibody for 30 min prior to incubation with the DNA probe. Complexes were separated by 4% SDS-polyacrylamide gel electrophoresis and exposed to autoradiography.
RESULTS

Ischemia Induces the Expression and Activation of STAT-1 in
Cardiomyocytes-Initially, we assessed whether cultured neonatal cardiomyocytes undergoing apoptosis induced by ischemia also show modulation of STAT-1. As shown in Fig. 1 , cardiomyocytes exposed to ischemia for 4 h showed increased STAT-1 expression. The induction of STAT-1 was increased further in cardiac cells that were exposed to 4 h of ischemia followed by 16 h of reoxygenation. Interestingly, it was observed that STAT-1 basal levels were consistently low in cardiac cells compared with a number of other cell types that we have studied. We also tested whether STAT-1 was activated by phosphorylation in response to ischemia using a specific antiphosphorylated STAT-1 antibody. As shown in Fig. 1 , exposure of cardiac cells to ischemia alone or ischemia/reoxygenation also resulted in the phosphorylation of STAT-1. In contrast, STAT-3 expression was not affected by ischemia (Fig. 1) . The findings that STAT-1 phosphorylation was detected by 4 h and that this level was sustained for a further 16 h were unexpected since most studies have shown that STAT-1 phosphorylation usually occurs as a transient and immediate response. It is therefore possible that secondary responses during simulated ischemia and followed by the reoxygenation phase may be responsible for sustained STAT-1 activation. In any case, these results indicate that the levels of both non-phosphorylated and phosphorylated forms of STAT-1 are increased after an ischemic stimulus.
To demonstrate that the STAT-1 protein induced in cardiomyocyte is able to bind DNA and to modulate gene transcription, we performed band shift assays with a specific STAT-1 oligonucleotide-binding site and also transient transfection experiments using the same STAT-1 DNA element coupled to a luciferase reporter construct. As shown in Fig. 1b, IFN -␥ produced a specific retarded band that was increased in the cell extract exposed to ischemia. This retarded band was abolished by an anti-STAT-1 antibody, but not anti-STAT-3 antibody, in nuclear extract from cardiomyocytes exposed to ischemia, thus identifying it as STAT-1. Furthermore, IFN-␥ treatment alone or exposure to simulated ischemia/reperfusion resulted in a 5-or 3-fold increase in promoter activity, respectively, thus indicating that exposure of cardiac cells to simulated ischemia/ reperfusion results in the activation of STAT-1 able to bind to DNA and to induce gene transcription.
As ischemia induced both STAT-1 activation and apoptosis, we wished to determine whether a similar association occurred following exposure to IFN-␥, which is known to activate STAT-1 in non-cardiac cells. As shown in Fig. 2a , exposure of cardiomyocytes to IFN-␥ resulted in activation and phosphorylation of STAT-1. Furthermore, IFN-␥ also increased the number of both TUNEL-and annexin V-positive cells, showing that IFN-␥ is inducing apoptotic cell death in cardiac cells as assessed by two distinct assays (Fig. 2b) . sion vector lacking the STAT-1 cDNA insert together with a ␤-galactosidase vector. Following ischemia, cardiac cells were then stained, and the number of nonviable and viable blue cells (LacZ) was assessed. Stained LacZ cells undergoing cell death are characterized by shrinkage and blebbing after 24 h following an ischemic stimulus. As shown in Fig. 3a , exposure to ischemia resulted in enhanced cell death in cardiac cells overexpressing STAT-1 compared with cells overexpressing the vector lacking the STAT-1 cDNA. In contrast, cardiac cells overexpressing STAT-1 alone without exposure to ischemia did not show enhanced cell death, suggesting that ischemia is necessary for the activation of STAT-1-induced cell death (Fig.  3a) .
STAT-1 and IFN-␥, but Not STAT-3, Promote Apoptosis in
To confirm a role for functional STAT-1 in ischemia-induced cell death, we repeated the above experiments, but transfected cardiac cells with a antisense STAT-1 vector to inhibit the endogenous expression of STAT-1 and then subjected these cells to ischemia. As shown in Fig. 3b , antisense STAT-1 reduced the level of cell death compared with the control vector following exposure to ischemia. These data strongly suggest that STAT-1 plays a role in ischemia-induced cell death in cardiac cells. Fig. 3c shows that the antisense STAT-1 vector reduced both the activation (ST1p) and induction (ST1) of STAT-1 in cardiac cells exposed to IFN-␥, demonstrating that the antisense STAT-1 vector is indeed inhibiting the levels of endogenous STAT-1 expression in transfected cardiac cells. To confirm that transfected cells overexpressing STAT-1 stained with ␤-galactosidase (LacZ) were indeed undergoing apoptosis, we also counterstained with TUNEL labeling. The number of TUNEL-positive cells paralleled the total amount of cell death obtained in Fig. 3a , with a greater number of apoptotic cardiomyocytes being observed following transfection of STAT-1 and exposure to ischemia/reperfusion compared with the control vector exposed to ischemia/reperfusion (Table I) . Thus, STAT-1-overexpressing cardiomyocytes that were exposed to simulated ischemia/reperfusion and that morphologically appeared as condensed and rounded cells were also TUNELpositive, suggesting that STAT-1 is indeed promoting apoptosis.
To determine whether induction of cell death was specific for STAT-1, we repeated these experiments, but transfected cardiac cells with an expression vector for STAT-3. As shown in Fig. 4a , overexpression of STAT-3 reduced the level of ischemia-induced apoptotic cell death. Moreover, STAT-3 also inhibited the effect of STAT-1 overexpression on apoptotic cell death in cardiac cells exposed to ischemia in a dose-dependent manner (Fig. 4a) . Fig. 4b also demonstrates that STAT-1 transfected cells expressed higher levels of STAT-1 than cells transfected with the control vector containing no STAT-1 cDNA insert. Cells transfected with the STAT-3 vector also expressed higher levels of STAT-3 compared with control cells in a dosedependent manner (Fig. 4a) . These results indicate that the relative levels of STAT-1/STAT-3 may be critical in determining susceptibility to cardiac cell death.
Caspase-1 Is a Target for STAT-1-The evidence that STAT-1 is involved in ischemia-induced cell death suggests that it may activate specific genes required for this process. Recently, IFN-␥ and STAT-1 have been shown to modulate the level of caspase-1 expression in non-cardiac cells (28) . Therefore, we performed studies to test whether the caspase-1 gene was modulated at the transcription level by transfection experiments using a caspase-1 promoter-luciferase reporter construct in cardiac cells exposed to either IFN-␥ or ischemia. As shown in Fig. 5a, IFN-␥ pression of STAT-1 together with IFN-␥ treatment further enhanced the activity of the caspase-1 promoter. Cardiomyocytes exposed to ischemia also transactivated the caspase-1 promoter (Fig. 5b) . Moreover, transfection of antisense STAT-1 inhibited both the IFN-␥/STAT-1-and ischemia-induced activation of the caspase-1 promoter (Fig. 5) . We also observed the active p20 form of caspase-1 in cardiac cells exposed to IFN-␥ or ischemia (data not shown). These results strongly suggest that the caspase-1 gene is a target for STAT-1 that could modulate the level of apoptosis in cardiac cells exposed to IFN-␥ or ischemia.
To examine this further, cardiomyocytes were pretreated with a specific inhibitor for caspase-1 protease (Tyr-Val-AlaAsp) and then exposed to IFN-␥ or ischemia. As shown in Fig.  6 , Tyr-Val-Ala-Asp blocked both IFN-␥-and ischemia-induced apoptosis. These results strongly suggest a role for caspase-1 in ischemia-and IFN-␥-induced cell death in cardiac cells that involves the activation of STAT-1.
Induction of Cardiac STAT-1 and Caspase-1 by Ischemia/ Reperfusion ex Vivo-Finally, we examined whether our in vitro data with cardiac cells on ischemia-induced apoptosis by STAT-1 and caspase-1 were also reproducible in the intact heart. Experiments were performed using 35-min coronary occlusion to simulate ischemia in the intact heart ex vivo in a Langendorff perfusion system. After the exposure to 35 min of ischemia, the hearts were reperfused for a further 2 h; then the left ventricles were removed, and Western blotting was performed to assess the levels of STAT-1 and caspase-1. As shown in Fig. 7a , the levels of both STAT-1 and phosphorylated STAT-1 were dramatically increased in ischemic ventricles compared with control ventricles. Moreover, the increased levels of STAT-1 were accompanied by increased cleavage of caspase-1 (Fig. 7b) .
The above data (Fig. 5 ) demonstrated that simulated ischemia/reperfusion increases the levels of the caspase-1 promoter in cardiac cells, but we were unable to observe an increase in the levels of the caspase-1 precursor in vitro and in the intact heart ex vivo. It is possible that the balance between the levels of precursor and the activation/cleavage of the active product is a rapid response, which may explain this observation. However, these results do suggest that ischemia-induced cell death is paralleled by the induction of STAT-1 and processing of caspase-1 ex vivo. Furthermore, immunofluorescent staining also demonstrated an increase in STAT-1-positive staining in ventricular tissue sections in response to ischemia/reperfusion that co-localized with TUNEL-positive myocytes (Table II) These results further support a key role for STAT-1 in ischemia/reperfusion-induced cell death in the intact heart. b, the caspase-1 promoter activity was examined in untreated cardiomyocytes or in cells exposed to ischemia for 4 h and reoxygenation for 16 h (Isch). Caspase-1 promoter activity was also assessed in cardiomyocytes transfected with antisense STAT-1 and exposed to ischemia for 4 h and reoxygenation for 16 h. In all cases, luciferase activity was assessed in a total of three experiments. ischemic stimulus leads to enhanced cell death in cardiac cells. Furthermore, inhibition of endogenous STAT-1 by a antisense STAT-1 construct greatly reduced the level of ischemia-induced cell death. Similarly, overexpression of STAT-3 reduced apoptosis induced by ischemia and by ischemia plus IFN-␥. Hence, these results indicate that STAT-1 is able to promote apoptosis in cardiac cells exposed to either IFN-␥ or ischemia and that STAT-3 antagonizes the STAT-1-mediated cell death pathway. We also show that one such STAT-1 target gene is caspase-1 and demonstrate proteolytic cleavage of the caspase-1 precursor in the perfused heart ex vivo in response to ischemia/reperfusion Several previous studies have identified a role for STAT-1 in the regulation of apoptosis in non-cardiac cells (16, 17, 28) . A STAT-1-deficient cell line is resistant to apoptosis by tumor necrosis factor-␣ (16), and we have evidence that these deficient cells are also resistant to ischemia-induced apoptosis (data not shown). IFN-␥, acting through STAT-1, is known to increase the expression of the death receptor Fas and its cognate ligand, FasL, thus promoting autocrine suicide (28) . Hence, the present data showing that overexpression of STAT-1 increases ischemia-and IFN-␥-induced apoptosis, whereas the antisense STAT-1 vector reduces it, are fully in accordance with these observations. Involvement of STAT-1 in pro-apoptotic signaling does not, however, preclude a role for other mediators. For example, in similar experiments, overexpression of p53 has also been shown to enhance ischemia-induced apoptosis in primary cultures of cardiomyocytes (29) . Moreover, p53 increases the activity of the Bax promoter, a pro-apoptotic Bcl-2 family member (30) . In addition, studies in our laboratory have shown that p53 is also able to inhibit the activity of the Bcl-2 promoter.
2 Since Bcl-2 and Bax can heterodimerize and since the ratio of Bcl-2 and Bax can determine susceptibility to apoptosis (31, 32) , p53, by enhancing the proportion of Bax in the heterodimer, will deliver a pro-apoptotic signal. Furthermore, other factors such as c-Myc, tumor necrosis factor-␣, and Fas have also been implicated in cardiac apoptosis (33) .
The apoptotic program is executed by activation of a cascade of proteases, the caspases. These have been divided into initiator (such as caspase-8 and -9) and effector (such as caspase-1, -3, and -6) caspases. The STAT-1-deficient cell line has low constitutive levels of caspase family members, consistent with its resistance to apoptosis (16) . Caspase-1-deficient cells are similarly refractory to apoptosis induced by IFN-␥ (17) . Our data showing that apoptosis is reduced by a caspase-1-specific inhibitor and that STAT-1 enhances caspase-1 expression are consistent with caspase-1 playing an important role in ischemia-and IFN-␥-induced apoptosis in the heart. However, the fact that some apoptosis was seen with a caspase-3-specific inhibitor (data not shown) suggests that other effector caspases such as caspase-3 may also be involved. Our finding that induction of STAT-1 co-localizes with TUNEL-positive nuclei is further evidence that STAT-1 plays a role in promoting apoptosis in the intact heart.
Our results also demonstrate that overexpression of STAT-3 can antagonize the apoptosis-promoting effects of STAT-1. STAT-1 and STAT-3 share a DNA-binding domain and phosphorylation sites for JAK and MAPK, and both these STATs can form heterodimers. We (36) and others (34, 35) have shown that the cytokines cardiotrophin-1 and leukemia inhibitory factor protect cardiac cells from apoptosis induced by ischemia and serum withdrawal, respectively, and that these protective effects are mediated through the MAPK pathway. This suggests that MAPK-mediated serine phosphorylation of STAT-3 may, after its heterodimerization, allow it to counteract the pro-apoptotic effects of STAT-1 that has been tyrosine-phosphorylated through a JAK pathway. This is in accordance with previous findings that JAK and MAPK converge to maximally activate STAT signaling (15) and that JAK and MAPK may interact to regulate apoptosis.
This study shows that STAT-1 and STAT-3 may interact to regulate apoptosis in the heart following an ischemic insult. Further studies are underway to determine other possible target genes for STAT-1 in mediating apoptosis in the heart during ischemia and other stressful stimuli. It is already clear that STAT-1 is likely to play a critical role in the regulation of ischemia-induced apoptosis in cardiomyocytes. A further understanding of the mechanism of STAT-1-induced apoptosis may lead to additional therapeutic approaches against damage to the heart caused by the induction of programmed cell death. 
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